GLP-3 RT is researched for simultaneous activation of three receptor pathways: GIP receptor activity enhances insulin sensitivity, GLP-1 receptor modulates appetite and glucose utilization, and glucagon receptor increases energy expenditure and hepatic glucose output.
This triple-agonist mechanism represents one of the most comprehensive approaches to metabolic research currently studied in preclinical settings.


Reviews
There are no reviews yet.